Skip to content

Clinical trials

Phase 3 Myocardial Infarction trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 3 Country / region: Netherlands Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20051
20062
20081
20091
20101
20112
20135
20141
20191
20201
20211
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated4
Active, not recruiting2
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
AstraZeneca2
Pfizer2
Sanofi2
Amsterdam UMC, location VUmc1
Bayer1
Boehringer Ingelheim1
CardioKinetix, Inc1
Centocor, Inc.1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction22
Stroke11
Cardiovascular Diseases8
Acute Coronary Syndrome4
Coronary Artery Disease4
Heart Failure4
Hyperlipidemias3
Angina, Unstable2
Heart Diseases2
Peripheral Arterial Disease2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.